Related Experiment Video
Updated: Jun 7, 2026
07:57
Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
Genetic determinants of plasma triglycerides.
Christopher T Johansen1, Sekar Kathiresan, Robert A Hegele
1Department of Biochemistry, Robarts Research Institute, University of Western Ontario, London, Ontario N6A 5K8, Canada.
Journal of Lipid Research
|November 3, 2010
Summary
Plasma triglyceride (TG) levels are key cardiovascular disease risk factors. Understanding genetic influences on TG metabolism is crucial for developing better risk prediction and therapeutic strategies.
Area of Science:
- Genetics
- Metabolic Disease
- Cardiovascular Disease
Background:
- Plasma triglyceride (TG) concentration is a significant risk factor for cardiovascular disease.
- Current genetic discoveries explain only a small portion of TG variation, necessitating further research.
- Existing therapies for hypertriglyceridemia are often challenging to manage.
Purpose of the Study:
- To review genes implicated in TG metabolism and their role in plasma TG concentration.
- To discuss insights gained from genomic and genetic approaches to TG metabolism.
- To explore potential new therapeutic targets for hypertriglyceridemia.
Main Methods:
- Review of recent genetic research, including genome-wide association studies (GWAS).
- Evaluation of alternative genetic strategies like rare variant sequencing and animal models.
- Analysis of gene products and pathways involved in TG metabolism.
Main Results:
- GWAS have identified known and novel loci associated with plasma TG, but explain limited variation.
- Alternative approaches like rare variant sequencing and animal models offer complementary insights.
- Recent genetic findings highlight specific gene products and pathways relevant to TG metabolism.
Conclusions:
- Further understanding of genetic factors influencing TG metabolism is essential for improved clinical applications.
- New therapeutic strategies for hypertriglyceridemia may emerge from ongoing genetic research.
- Identifying genetic determinants of TG metabolism holds promise for personalized medicine in cardiovascular disease prevention.
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...